Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Watchlist | Portfolio

Keryx Biopharm Inc (KERX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2017	12-2016	12-2015	12-2014	12-2013
Assets
Current Assets
Cash & Cash Equivalents	93,526	111,810	200,290	74,284	55,696
Marketable Securities	N/A	N/A	N/A	11,508	N/A
Receivables	8,146	5,236	4,293	834	N/A
Inventories	28,695	12,681	41,881	7,830	N/A
Other current assets	11,199	3,170	2,830	4,140	1,232
TOTAL	$141,566	$132,897	$249,294	$98,596	$56,928

Non-Current Assets
PPE Net	4,521	4,211	5,083	1,532	349
Intangibles	3,208	3,208	3,208	3,208	3,208
Other Non-Current Assets	9,577	1,111	1,100	292	281
TOTAL	$17,306	$8,530	$9,391	$5,032	$3,838

Total Assets	$158,872	$141,427	$258,685	$103,628	$60,766

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	45,031	21,190	26,795	24,146	14,004
Accrued Expenses	N/A	N/A	N/A	4,751	1,324
Other current liabilities	389	361	47,285	N/A	N/A
TOTAL	$45,420	$21,551	$77,606	$29,311	$15,328

Non-Current Liabilities
Deferred Revenues	N/A	N/A	3,526	414	N/A
Other Non-Current Liabilities	126,912	127,302	93,355	133	38
TOTAL	$127,547	$128,172	$94,145	$833	$38

Total Liabilities	$172,967	$149,723	$171,751	$30,144	$15,366

Shareholders' Equity
Shares Outstanding, K	119,176	107,668	105,876	103,596	90,912
Common Shares	119	106	105	93	83
Retained earnings	-998,538	-835,098	-674,003	-550,858	-439,340
Other shareholders' equity	-357	-357	-357	-357	-357
TOTAL	$-14,095	$-8,296	$86,934	$73,484	$45,400

Total Liabilities And Equity	$158,872	$141,427	$258,685	$103,628	$60,766